[1]
P. Duraisamy, V. Panicker, and W. Jose, “Characterization and Prognostic Significance of Cutaneous Immune-Related Adverse Events in Indian Patients on Immune Checkpoint Inhibitor Therapy”, Dermatol Pract Concept, vol. 13, no. 3, p. e2023127, Jul. 2023, doi: 10.5826/dpc.1303a127.